Health Insurance Agents and Marketers. Health Insurance web Directory: Dental Insurance, Disability Insurance, Discount Plans and quotes, Long Term Care Health Insurance, Medical Savings Accounts - all Health insurance information in one searchable Directory. List of companies offering health insurance to individuals and businesses, information on the kinds of health insurance by product, services or company.
Houma Health Insurance Service
Specializing in insurance benefits for group and individual health, life, disability, long term care, dental and vision insurance. Site offers detailed explanation of products.
Option One Dental Plan
Reduced fee dental plan for Illinois, Indiana, Iowa, and Missouri. Benefits include orthodontics. Apply online.
More signs that US births may have stopped falling
ATLANTA (AP) — There's more evidence that U.S. births may be leveling off after years of decline.
Face transplants thriving 2 years after operations
FDA approves breakthrough hepatitis C drug
CHICAGO (AP) — The nation's first full face transplant patients are growing into their new appearances — literally.
WASHINGTON (AP) — Federal health officials have approved a highly anticipated hepatitis C drug from Gilead Sciences Inc. that is expected to offer a faster, more palatable cure to millions of people infected with the liver-destroying virus.
FDA approves Gilead's $1,000-a-day hepatitis C pill
(Reuters) - U.S. regulators on Friday approved Gilead Sciences Inc's Sovaldi as a potentially easier cure for chronic infection with the liver-destroying hepatitis C virus. The once-a-day pill is the first approved to treat certain types of hepatitis C infection without the need for interferon, an injected drug that can cause severe flu-like symptoms. Hepatitis C, which is often undiagnosed, affects about 3.2 million Americans, killing more than 15,000 each year, mostly from illnesses such as cirrhosis and liver cancer. Most patients will be treated with the $1,000-a-day drug for 12 weeks, resulting in a total list price of $84,000, according to Gilead spokeswoman Cara Miller.